Td Private Client Wealth LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Td Private Client Wealth LLC
- $4.44 Trillion
- Q3 2025
A detailed history of Td Private Client Wealth LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 18 shares of ARWR stock, worth $681. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$681% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
332Shares Held
99.7MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$594 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$588 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$401 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$241 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$198 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.01B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...